Found: 51
Select item for more details and to access through your institution.
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 5, p. 491, doi. 10.1007/s11912-023-01377-6
- By:
- Publication type:
- Article
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high‐risk characteristics by molecular expression profiling.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 3, p. 175, doi. 10.1002/gcc.22716
- By:
- Publication type:
- Article
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920973130
- By:
- Publication type:
- Article
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.
- Published in:
- Breast Care, 2024, v. 19, n. 3, p. 183, doi. 10.1159/000538753
- By:
- Publication type:
- Article
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.
- Published in:
- Breast Care, 2024, v. 19, n. 3, p. 165, doi. 10.1159/000538596
- By:
- Publication type:
- Article
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation.
- Published in:
- Breast Care, 2023, v. 18, n. 6, p. 455, doi. 10.1159/000534670
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.
- Published in:
- Breast Care, 2023, v. 18, n. 4, p. 305, doi. 10.1159/000531579
- By:
- Publication type:
- Article
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.
- Published in:
- Breast Care, 2023, v. 18, n. 4, p. 288, doi. 10.1159/000531578
- By:
- Publication type:
- Article
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00403-3
- By:
- Publication type:
- Article
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0168-9
- By:
- Publication type:
- Article
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4884, doi. 10.3390/cancers13194884
- By:
- Publication type:
- Article
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1902, doi. 10.3390/cancers12071902
- By:
- Publication type:
- Article
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 6, p. 1060, doi. 10.1002/1878-0261.13435
- By:
- Publication type:
- Article
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 573, doi. 10.1007/s10549-017-4358-6
- By:
- Publication type:
- Article
The prognostic impact of age in different molecular subtypes of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 3, p. 667, doi. 10.1007/s10549-015-3491-3
- By:
- Publication type:
- Article
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 2, p. 279, doi. 10.1007/s10549-015-3310-x
- By:
- Publication type:
- Article
Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 3, p. 643, doi. 10.1007/s10549-011-1377-6
- By:
- Publication type:
- Article
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8581, doi. 10.1002/cam4.4376
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
- Published in:
- Breast Care, 2022, v. 17, n. 4, p. 403, doi. 10.1159/000524879
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.
- Published in:
- Breast Care, 2022, v. 17, n. 4, p. 421, doi. 10.1159/000524789
- By:
- Publication type:
- Article
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.
- Published in:
- Breast Care, 2021, v. 16, n. 5, p. 475, doi. 10.1159/000512416
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021.
- Published in:
- Breast Care, 2021, v. 16, n. 3, p. 214, doi. 10.1159/000516419
- By:
- Publication type:
- Article
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021.
- Published in:
- Breast Care, 2021, v. 16, n. 3, p. 228, doi. 10.1159/000516420
- By:
- Publication type:
- Article
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
- Published in:
- Breast Care, 2021, v. 16, n. 2, p. 173, doi. 10.1159/000507473
- By:
- Publication type:
- Article
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
- Published in:
- Breast Care, 2021, v. 16, n. 1, p. 50, doi. 10.1159/000506622
- By:
- Publication type:
- Article
Luminal Breast Cancer: The Head of Janus in Breast Oncology.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
- Published in:
- Breast Care, 2020, v. 15, n. 3, p. 294, doi. 10.1159/000508736
- By:
- Publication type:
- Article
ASCO 2019: New Results in Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding
Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients.
- Published in:
- Breast Care, 2019, v. 14, n. 3, p. 159, doi. 10.1159/000491792
- By:
- Publication type:
- Article
Genomic Profiling in Luminal Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast Cancers.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Kongressbericht vom 3. Brustkrebskongress Köln und Niederrhein.
- Published in:
- Breast Care, 2010, v. 5, n. 1, p. 47, doi. 10.1159/000280103
- By:
- Publication type:
- Article
Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 6, p. 1433, doi. 10.1002/ijc.23628
- By:
- Publication type:
- Article
Trastuzumab emtansine (T-DM1) renders HER2<sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aac4925
- By:
- Publication type:
- Article
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 10, p. 2614, doi. 10.1002/ijc.33495
- By:
- Publication type:
- Article
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 1, p. 262, doi. 10.1002/ijc.32488
- By:
- Publication type:
- Article
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 882, doi. 10.1002/ijc.30078
- By:
- Publication type:
- Article
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0160077
- By:
- Publication type:
- Article
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- Published in:
- Trials, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1745-6215-14-261
- By:
- Publication type:
- Article
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1715, doi. 10.1038/s41416-021-01690-6
- By:
- Publication type:
- Article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4847, doi. 10.1002/cncr.33104
- By:
- Publication type:
- Article
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib.
- Published in:
- BioDrugs, 2019, v. 33, n. 2, p. 125, doi. 10.1007/s40259-019-00337-6
- By:
- Publication type:
- Article